ARCHIVE

• Reform Should Promote Industry: LDP Diet Member
  February 25, 2002

• Matsumotokiyoshi Ties Up with Shimizu Yakuhin
  February 25, 2002

• PFSB to Computerize All Administrative Procedures in FY2003
  February 25, 2002

• Suzuken: New Blood Pressure Monitors
  February 25, 2002

• Medical Institutions Should Join Discussions on Distribution Reform: Mr Matsutani of FJPWA
  February 25, 2002

• Bio Media: New Sprayer for Sterilization
  February 25, 2002

• Yamanouchi Expects 50% of Its Asian Sales in China
  February 25, 2002

• AstraZeneca: Sales Up 8% to US$16,480 Mil.
  February 25, 2002

• JPMA to Continue to Demand Better Protection of NDA Dossiers
  February 25, 2002

• Quintiles: 4th Qtr Sales US$404 Million
  February 25, 2002

• ICH ETWG Compiles Q&A for Implementation of CTD
  February 25, 2002

• Sanofi-Synthelabo, Organon Launch Arixtra in US
  February 25, 2002

• Hayashibara's IFN-a to Be Approved in South Korea
  February 18, 2002

• REGULATORY NEWS IN BRIEF
  February 18, 2002

• Japanese Global Strategy Update (7)
  February 18, 2002

• Slowdown of Buying Activities Not Seen in Market
  February 18, 2002

• Kusuri Proverbs Reveal Japanese Spirit (3)
  February 18, 2002

• Chugai Transfers Marketing Rights of Keiten to Fujisawa
  February 18, 2002

• Drug Makers Should Conclude Labor Contracts with Hospitals for PMS: Pharmacy Expert
  February 18, 2002

• Novartis Transfers Marketing Rights for Halospor to Toyama
  February 18, 2002

ページ

• « 先頭
• ‹ Prev
• …
• 698
• 699
• 700
• 701
• 702
• 703
• 704
• 705
• 706
• …
• Next ›
• 最終 »